EcoR1 Capital, LLC, Director, 10% Owner at Zymeworks Inc. (ZYME), bought 260,618 shares at $14.49 ($3.8M) on 2024-12-27, disclosed to the SEC on 2024-12-27.
Open-market purchase of $3.8M ZYME by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.12 | 11,958 | $169K | 4.5% |
| 2 | $14.12 | 11,958 | $169K | 4.5% |
| 3 | $14.38 | 16,692 | $240K | 6.4% |
| 4 | $14.38 | 16,692 | $240K | 6.4% |
| 5 | $14.49 | 101,659 | $1.5M | 39.1% |
| 6 | $14.49 | 101,659 |
| $1.5M |
| 39.1% |
| Total | $14.44 avg | 260,618 | $3.8M | 100% |
| Filing → |
| AKTS | BUY | 2026-01-12 | $40.0M | — | Filing → |
| ADAP | SELL | 2025-07-30 | $13.2M | — | Filing → |
| ZYME | BUY | 2025-05-19 | $1.3M | — | Filing → |